16/03/2017                    
A new class of inhibitors against pain investigated at the ALBA synchrotron
        A new class of inhibitors against pain investigated at the ALBA synchrotron
                                        The pharmaceutical company ESTEVE (2,470 people, 916 million Euros income in 2016), the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron joined together to investigate the mechanism of action of new inhibitors against pain developed by the company.
Getting new information about the interactions, active site and mechanism of action of the developed drugs and the therapeutic target may help to the better understanding of the effects of the inhibitors and can provide key information to improve their properties. In that sense, the XALOC ALBA beam line offers a valuable tool for carrying out the corresponding experiments.
As a first step, the research will be carried out at the Protein Production Platform of the UAB to obtain the pure protein complexed with the inhibitors. Secondly, X-ray crystallography studies will be performed at the biolab and in ALBA.
This project is a good example of public-private collaboration that fosters the synergies and relationships between the industrial and academic sectors to advance research and innovation.
                    
                                
                 
            Getting new information about the interactions, active site and mechanism of action of the developed drugs and the therapeutic target may help to the better understanding of the effects of the inhibitors and can provide key information to improve their properties. In that sense, the XALOC ALBA beam line offers a valuable tool for carrying out the corresponding experiments.
As a first step, the research will be carried out at the Protein Production Platform of the UAB to obtain the pure protein complexed with the inhibitors. Secondly, X-ray crystallography studies will be performed at the biolab and in ALBA.
This project is a good example of public-private collaboration that fosters the synergies and relationships between the industrial and academic sectors to advance research and innovation.
More news
        		        	
            	
                	02/11/2018                 
                Food packaging? ALBA!            
                	
            	
                	25/10/2018                 
                SENER: on the way to Mercury!            
                	
            	
                	18/10/2018                 
                The Barcelona Industry Week promotes the (4.0) revolution             
                	
            	
                	11/10/2018                 
                Everything you’ve always wanted to know about Alba synchrotron            
                	
            	
                	04/10/2018                 
                Parks: the importance of infrastructures            
                	
            	
                	27/09/2018                 
                Catalan Minister of Business and Knowledge visits the park            
                    
        
        
        
    
 
                                     
                            		
                             
                                     
                            		
                             
                                     
                            		
                             
                
 
     home
home